Effects of low-dose aspirin on gastric erosions, cyclooxygenase expression and mucosal prostaglandin-E 2 do not depend on Helicobacter pylori infection

Alimentary Pharmacology and Therapeutics

Volumn 23, Issue 8, 2006, Pages 1225-1233

  Venerito, M ^a   Treiber, G ^a   Wex, T ^a   Kuester, D ^b   Roessner, A ^b   Di Mario, F ^c   Malfertheiner, P ^a,b  

^a Department of Gastroenterology Hepatology and Infectious Diseases   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERADICATION THERAPY; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; HELICOBACTER INFECTION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOW DRUG DOSE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN EXPRESSION; RANK SUM TEST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH EROSION; STOMACH MUCOSA;

ADULT; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CASE-CONTROL STUDIES; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINOPROSTONE; DRUG ADMINISTRATION SCHEDULE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STATISTICS, NONPARAMETRIC;

EID: 33646860568     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.02856.x     Document Type: Article

References (35)

1. Hunt RH Bazzoli F. Review article: should NSAID/low-dose aspirin takers be tested routinely for H. pylori infection and treated if positive? Implications for primary risk of ulcer and ulcer relapse after initial healing. Aliment Pharmacol Ther 2004 19 : 9 16.
2. Hoshino T Tsutsumi S Tomisato W Hwang HJ Tsuchiya T Mizushima T. Prostaglandin E2 protects gastric mucosal cells from apoptosis via EP2 and EP4 receptor activation. J Biol Chem 2003 278 : 12752 8.
3. Warner TD Mitchell JA. Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. FASEB J 2004 18 : 790 804.
4. Halter F Tarnawski AS Schmassmann A Peskar BM. Cyclooxygenase 2-implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives. Gut 2001 49 : 443 53.
5. Weissmann G. Aspirin. Sci Am 1991 264 : 84 90.
6. Smith WL Dewitt DL Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 2000 69 : 145 82.
7. Weil J Colin-Jones D Langman M, et al. Prophylactic aspirin and risk of peptic ulcer bleeding. Br Med J 1995 310 : 827 30.
8. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971 231 : 232 5.
9. Stange EF Preclik G Gerber K, et al. Prostaglandin synthesis in stomach and duodenal mucosa of the human: effect of aspirin with and without antacid. Z Gastroenterol 1987 25 : 162 5.
10. Lee M Cryer B Feldman M. Dose effects of aspirin on gastric prostaglandins and stomach mucosal injury. Ann Intern Med 1994 120 : 184 9.
11. Suerbaum S Michetti P. Helicobacter pylori infection. N Engl J Med 2002 347 : 1175 86.
12. Romano M Ricci V Memoli A, et al. Helicobacter pylori up-regulates cyclooxygenase-2 mRNA expression and prostaglandin E2 synthesis in MKN 28 gastric mucosal cells in vitro. J Biol Chem 1998 273 : 28560 3.
13. Konturek JW Dembinski A Konturek SJ Stachura J Domschke W. Infection of Helicobacter pylori in gastric adaptation to continued administration of aspirin in humans. Gastroenterology 1998 114 : 245 55.
14. McCarthy CJ Crofford LJ Greenson J Scheiman JM. Cyclooxygenase-2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infection. Am J Gastroenterol 1999 94 : 1218 23.
15. Kim JS Kim JM Jung HC Song IS. Expression of cyclooxygenase-2 in human neutrophils activated by Helicobacter pylori water-soluble proteins: possible involvement of NF-kappaB and MAP kinase signaling pathway. Dig Dis Sci 2001 46 : 2277 84.
16. Meyer F Ramanujam KS Gobert AP James SP Wilson KT. Cutting edge: cyclooxygenase-2 activation suppresses Th1 polarization in response to Helicobacter pylori. J Immunol 2003 171 : 3913 7.
17. Futagami S Hiratsuka T Tatsuguchi A, et al. Monocyte chemoattractant protein 1 (MCP-1) released from Helicobacter pylori stimulated gastric epithelial cells induces cyclooxygenase 2 expression and activation in T cells. Gut 2003 52 : 1257 64.
18. Jackson LM Wu KC Mahida YR Jenkins D Hawkey CJ. Cyclooxygenase (COX) 1 and 2 in normal, inflamed, and ulcerated human gastric mucosa. Gut 2000 47 : 762 70.
19. Tatsuguchi A Sakamoto C Wada K, et al. Localisation of cyclooxygenase 1 and cyclooxygenase 2 in Helicobacter pylori related gastritis and gastric ulcer tissues in humans. Gut 2000 46 : 782 9.
20. Nardone G Rocco A Vaira D, et al. Expression of COX-2, mPGE-synthase1, MDR-1 (P-gp), and Bcl-xL: a molecular pathway of H. pylori-related gastric carcinogenesis. J Pathol 2004 202 : 305 12.
21. Dixon MF Genta RM Yardley JH Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996 20 : 1161 81.
22. Malfertheiner P Enrique D Heckenmuller H Neubrand M Fischer HP Sauerbruch T. Modified rapid urease test for detection of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1996 8 : 53 6.
23. Leodolter A Dominguez-Munoz JE von Arnim U Kahl S Peitz U Malfertheiner P. Validity of a modified 13C-urea breath test for pre- and posttreatment diagnosis of Helicobacter pylori infection in the routine clinical setting. Am J Gastroenterol 1999 94 : 2100 4.
24. Wex T Treiber G Lendeckel U Malfertheiner P. A two-step method for the extraction of high-quality RNA from endoscopic biopsies. Clin Chem Lab Med 2003 41 : 1033 7.
25. Feldman M Shewmake K Cryer B. Time course inhibition of gastric and platelet COX activity by acetylsalicylic acid in humans. Am J Physiol Gastrointest Liver Physiol 2000 279 : G1113 20.
26. Cryer B Feldman M. Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans. Gastroenterology 1999 117 : 17 25.
27. Wallace JL Zamuner SR McKnight W, et al. Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammation. Am J Physiol Gastrointest Liver Physiol 2004 286 : G76 81.
28. Fiorucci S Santucci L Wallace JL, et al. Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa. Proc Natl Acad Sci USA 2003 100 : 10937 41.
29. Cryer B Lee E Feldman M. Factors influencing gastroduodenal mucosal prostaglandin concentrations: roles of smoking and aging. Ann Intern Med 1992 116 : 636 40.
30. Hudson N Balsitis M Filipowicz F Hawkey CJ. Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs. Gut 1993 34 : 748 51.
31. Mertz-Nielsen A Hillingso J Frokiaer H Bukhave K Rask-Madsen J. Gastric bicarbonate secretion and release of prostaglandin E2 are increased in duodenal ulcer patients but not in Helicobacter pylori-positive healthy subjects. Scand J Gastroenterol 1996 31 : 38 43.
32. Cryer B Faust TW Goldschmiedt M Redfern JS Lee E Feldman M. Gastric and duodenal mucosal prostaglandin concentrations in gastric or duodenal ulcer disease: relationships with demographics, environmental, and histological factors, including Helicobacter pylori. Am J Gastroenterol 1992 87 : 1747 54.
33. Preclik G Abedin G Stange EF Baczako K Ditschuneit H. Endogenous prostaglandin synthesis and gastritis: lack of correlation with endoscopic findings, Helicobacter colonization and leukocytic infiltration of the mucosa. Z Gastroenterol 1992 30 : 130 3.
34. Fu S Ramanujam KS Wong A, et al. Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenterology 1999 116 : 1319 29.
35. Wu CY Wu MS Chen CJ Li MC Lin JT Chen GH. The interaction of H. pylori infection and NSAIDs in cyclooxygenase-2 mRNA expression in gastric antral, corpus mucosa, and gastric ulcer. J Clin Gastroenterol 2005 39 : 50 5.